Evidence map›Paper›PMID 29635772›Full record

ArticleMicrobial biotechnology2018

Biogenic selenium nanoparticles synthesized by Stenotrophomonas maltophilia SeITE02 loose antibacterial and antibiofilm efficacy as a result of the progressive alteration of their organic coating layer.

Eleonora Cremonini, Marzia Boaretti, Ilse Vandecandelaere, Emanuele Zonaro, Tom Coenye, Maria M Lleo, Silvia Lampis, Giovanni Vallini

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Investigation of the Antibacterial and Antibiofilm Activity of Selenium Nanoparticles againstThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Article
  14. Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Eleonora CremoniniDepartment of Diagnostic and Public Health, University of Verona, Strada Le Grazie 8, 37134, Verona, Italy.
Marzia BoarettiDepartment of Diagnostic and Public Health, University of Verona, Strada Le Grazie 8, 37134, Verona, Italy.ORCID 0000-0003-0565-468X
Ilse VandecandelaereLaboratory of Pharmaceutical Microbiology, Ghent University, Ottergemsesteenweg 460, 9000, Gent, Belgium.
Emanuele ZonaroDepartment of Biotechnology, University of Verona, Strada Le Grazie 15, 37134, Verona, Italy.
Tom CoenyeLaboratory of Pharmaceutical Microbiology, Ghent University, Ottergemsesteenweg 460, 9000, Gent, Belgium.
Maria M LleoDepartment of Diagnostic and Public Health, University of Verona, Strada Le Grazie 8, 37134, Verona, Italy.
Silvia LampisDepartment of Biotechnology, University of Verona, Strada Le Grazie 15, 37134, Verona, Italy.
Giovanni ValliniDepartment of Biotechnology, University of Verona, Strada Le Grazie 15, 37134, Verona, Italy.
University of Verona · ITGhent University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing emergence of drug-resistant microorganisms poses a great concern to clinicians; thus, new active products are urgently required to treat a number of infectious disease cases. Different metallic and metalloid nanoparticles have so far been reported as possessing antimicrobial properties and proposed as a possible alternative therapy against resistant pathogenic microorganisms. In this study, selenium nanoparticles (SeNPs) synthesized by the environmental bacterial isolate Stenotrophomonas maltophilia SeITE02 were shown to exert a clear antimicrobial and antibiofilm activity against different pathogenic bacteria, either reference strains or clinical isolates. Antimicrobial and antibiofilm capacity seems to be strictly linked to the organic cap surrounding biogenic nanoparticles, although the actual role played by this coating layer in the biocidal action remains still undefined. Nevertheless, evidence has been gained that the progressive loss in protein and carbohydrate content of the organic cap determines a decrease in nanoparticle stability. This leads to an alteration of size and electrical properties of SeNPs along with a gradual attenuation of their antibacterial efficacy. Denaturation of the coating layer was proved even to have a negative effect on the antibiofilm activity of these nanoparticles. The pronounced antimicrobial efficacy of biogenic SeNPs compared to the denatured ones can - in first instance - be associated with their smaller dimensions. This study showed that the native organic coating layer of biogenic SeNPs functions in avoiding aggregation and maintaining electrostatic stability of the nanoparticles, thus allowing them to maintain efficient antimicrobial and antibiofilm capabilities.

Indexed as

Anti-Bacterial AgentsBacteriaBacterial Physiological PhenomenaBiofilmsNanoparticlesSeleniumStatic ElectricityStenotrophomonas maltophiliaAnti-Bacterial AgentsSelenium

Identifiers

PMID29635772
PMCPMC6196382
OpenAlexW2798148647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.